![BT-SR-Feature BT-SR-Feature](https://edpa.org/wp-content/uploads/2020/09/BT-SR-Feature.jpg)
How Southern Research in Birmingham leads global fight against COVID-19
Share
Scientists at Birmingham-based Southern Research are front-runners in the global race to develop new vaccines and therapeutic treatments against COVID-19, the disease caused by the novel coronavirus that is blamed for a growing death toll and massive economic fallout worldwide.
The work now taking place in the organization’s laboratories builds upon decades of multi-faceted research in infectious diseases and efforts targeting the discovery and development of medicines to treat numerous illnesses.
“We fully understand the urgency and need to accelerate drug discovery and development activities to help curb the coronavirus pandemic,” said Michael Catalano, Southern Research’s interim chief operating officer. “Southern Research is honored to play a role in the world’s health and safety. Biological science developments, such as this collaboration, are core to our nearly 80-year mission.”
To read more of the story, please go to: alabamanewscenter/southernresearch